Replimune Group Inc (REPL)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Philip Astley-Sparke
Employees:
210
18 COMMERCE WAY, WOBURN, MA 01801
781-995-2443

Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer.

Data derived from most recent annual or quarterly report
Market Cap 1.05 Billion Shares Outstanding56.655 Million Avg 30-day Volume 476.009 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.99
Price to Revenue0.0 Debt to Equity0.0947 EBITDA-183.033 Million
Price to Book Value1.8514 Operating Margin0.0 Enterprise Value497.269 Million
Current Ratio17.52 EPS Growth-0.323 Quick Ratio17.247
1 Yr BETA 1.0884 52-week High/Low 29.52 / 13.84 Profit Margin0.0
Operating Cash Flow Growth-55.8165 Altman Z-Score5.8241 Free Cash Flow to Firm -132.901 Million
Earnings Report2023-08-03
View SEC Filings from REPL instead.

View recent insider trading info

Replimune Group Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding REPL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding REPL

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 3: filed on 2023-05-18 by SCHWENDENMAN ANDREW
  • 4: filed on 2023-05-18 by PATEL SUSHIL
  • 4: filed on 2023-05-18 by COFFIN ROBERT
  • 4: filed on 2023-05-18 by LEWIS TANYA
  • 4: filed on 2023-05-18 by LOVE COLIN
  • 4: filed on 2023-05-18 by FRANCHI JEAN M.
  • 4: filed on 2023-05-18 by XYNOS KONSTANTINOS
  • 4: filed on 2023-05-18 by ESPOSITO PAMELA
  • 4: filed on 2023-05-18 by Astley-Sparke Philip
  • 4: filed on 2023-04-04 by SLOOTWEG HUGO ALEXANDER

    • Events (8k)

  • 8-K: filed on 2023-05-18:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-27:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-04:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-12:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-07:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-07:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-08:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    82.4 Thousand total shares from 8 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SCHWENDENMAN ANDREW CHIEF ACCOUNTING OFFICER

    • Officer
    		 22,761 2023-05-18 1

    ASTLEY-SPARKE PHILIP CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 1,525,278 2023-05-16 2

    COFFIN ROBERT PRESIDENT & CHIEF R&D OFFICER

    • Officer
    • Director
    		 1,833,336 2023-05-16 2

    LOVE COLIN CHIEF OPERATING OFFICER

    • Officer
    		 794,960 2023-05-16 2

    LEWIS TANYA CHIEF DEV. OP. OFFICER

    • Officer
    		 148,153 2023-05-16 2

    FRANCHI JEAN M. CHIEF FINANCIAL OFFICER

    • Officer
    		 128,748 2023-05-16 2

    ESPOSITO PAMELA CHIEF BUSINESS OFFICER

    • Officer
    		 263,436 2023-05-16 3

    PATEL SUSHIL CHIEF STRATEGY OFFICER

    • Officer
    		 154,571 2023-05-16 2

    XYNOS KONSTANTINOS CHIEF MEDICAL OFFICER

    • Officer
    		 120,027 2023-05-16 4

    SLATTERY JOSEPH P

    • Director
    		 0 2023-04-01 1

    LEVITSKY HYAM

    • Director
    		 0 2023-04-01 1

    PUCCI PAOLO

    • Director
    		 0 2023-04-01 1

    DHINGRA KAPIL

    • Director
    		 0 2023-04-01 1

    WEINAND DIETER

    • Director
    		 0 2023-04-01 1

    SLOOTWEG HUGO ALEXANDER

    • Director
    		 0 2023-04-01 1

    OLIGER CHRISTY J.

    • Director
    		 0 2023-04-01 1

    RHODES JASON P

    • Director
    		 16,500 2022-04-01 0

    OMEGA FUND IV, L.P.

    OMEGA FUND IV GP, L.P.

    OMEGA FUND IV G.P. MANAGER, LTD.

    STAMPACCHIA OTELLO

    • 10% Owner
    		 4,673,380 2022-03-14 0

    OMEGA FUND IV, L.P.

    OMEGA FUND IV GP, L.P.

    OMEGA FUND IV G.P. MANAGER, LTD.

    STAMPACCHIA OTELLO

    PASTER ANNE-MARI

    • Director
    • 10% Owner
    		 16,500 2021-04-01 0

    PIRZKALL ANDREA CHIEF MEDICAL OFFICER

    • Officer
    		 52,250 2021-04-01 0

    ATLAS VENTURE FUND X, L.P.

    • 10% Owner
    		 No longer subject to file 2020-09-15 0

    GORGOL STEPHEN A CHIEF ACCOUNTING OFFICER

    • Officer
    		 0 2020-04-01 0

    KAUFMAN HOWARD CHIEF MEDICAL OFFICER

    • Officer
    		 58,067 2019-11-26 0

    ATLAS VENTURE OPPORTUNITY FUND I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

    • SEE REMARKSSEE REMARKSSEE REMARKS
    		 1,100,000 2019-11-18 0

    OMEGA FUND IV, L.P.

    OMEGA FUND IV GP, L.P.

    OMEGA FUND IV G.P. MANAGER, LTD.

    STAMPACCHIA OTELLO

    LIM RICHARD J.

    PASTER ANNE-MARI

    • Director
    • 10% Owner
    		 0 2019-04-01 0

    BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC

    BAIN CAPITAL LIFE SCIENCES PARTNERS, LP

    BAIN CAPITAL LIFE SCIENCES FUND, L.P.

    BCIP LIFE SCIENCES ASSOCIATES, LP

    SCHWARTZ JEFFREY LAWRENCE

    KOPPEL ADAM

    • Director
    • 10% Owner
    		 No longer subject to file 2018-07-24 0

    FORBION CAPITAL FUND III COOPERATIEF U.A.

    • 10% Owner
    		 4,721,449 2018-07-24 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    PATEL SUSHIL - Officer CHIEF STRATEGY OFFICER

    		2023-05-18 20:36:09 -0400 2023-05-16 S 15,575 $18.05 d 154,571 direct 0.6129 -0.4597 0.6129 2 -2.8601 4

    COFFIN ROBERT - Director - Officer PRESIDENT & CHIEF R&D OFFICER

    		2023-05-18 20:35:22 -0400 2023-05-16 S 7,861 $18.05 d 1,833,336 direct 0.6129 -0.4597 0.6129 2 -2.8601 4

    LEWIS TANYA - Officer CHIEF DEV. OP. OFFICER

    		2023-05-18 20:34:34 -0400 2023-05-16 S 12,207 $18.05 d 148,153 direct 0.6129 -0.4597 0.6129 2 -2.8601 4

    LOVE COLIN - Officer CHIEF OPERATING OFFICER

    		2023-05-18 20:33:38 -0400 2023-05-16 S 10,775 $18.05 d 794,960 direct 0.6129 -0.4597 0.6129 2 -2.8601 4

    FRANCHI JEAN M. - Officer CHIEF FINANCIAL OFFICER

    		2023-05-18 20:32:47 -0400 2023-05-16 S 11,351 $18.05 d 128,748 direct 0.6129 -0.4597 0.6129 2 -2.8601 4

    XYNOS KONSTANTINOS - Officer CHIEF MEDICAL OFFICER

    		2023-05-18 20:31:48 -0400 2023-05-16 S 771 $18.05 d 120,027 direct 0.6129 -0.4597 0.6129 2 -2.8601 4

    ESPOSITO PAMELA - Officer CHIEF BUSINESS OFFICER

    		2023-05-18 20:31:06 -0400 2023-05-16 S 5,966 $18.05 d 263,436 direct 0.6129 -0.4597 0.6129 2 -2.8601 4

    ASTLEY-SPARKE PHILIP - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-05-18 20:30:25 -0400 2023-05-16 S 17,902 $18.05 d 1,525,278 direct 0.6129 -0.4597 0.6129 2 -2.8601 4

    COFFIN ROBERT - Director - Officer PRESIDENT & CHIEF R&D OFFICER

    		2023-04-04 20:00:41 -0400 2023-04-01 A 67,500 a 67,500 direct

    OLIGER CHRISTY J. - Director

    		2023-04-04 20:02:55 -0400 2023-04-01 A 25,200 a 25,200 direct

    WEINAND DIETER - Director

    		2023-04-04 20:03:18 -0400 2023-04-01 A 37,800 a 37,800 direct

    LEVITSKY HYAM - Director

    		2023-04-04 20:03:28 -0400 2023-04-01 A 25,200 a 25,200 direct

    SLATTERY JOSEPH P - Director

    		2023-04-04 20:03:47 -0400 2023-04-01 A 25,200 a 25,200 direct

    DHINGRA KAPIL - Director

    		2023-04-04 20:03:56 -0400 2023-04-01 A 25,200 a 25,200 direct

    PUCCI PAOLO - Director

    		2023-04-04 20:04:14 -0400 2023-04-01 A 25,200 a 25,200 direct

    SLOOTWEG HUGO ALEXANDER - Director

    		2023-04-04 20:04:24 -0400 2023-04-01 A 25,200 a 25,200 direct

    ASTLEY-SPARKE PHILIP - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-04-04 20:00:30 -0400 2023-04-01 A 142,100 a 1,543,180 direct 1.3931 -1.4537 18.9582 18.9582 31 -5.209 5

    COFFIN ROBERT - Director - Officer PRESIDENT & CHIEF R&D OFFICER

    		2023-04-04 20:00:41 -0400 2023-04-01 A 45,000 a 1,841,197 direct 1.3931 -1.4537 18.9582 18.9582 31 -5.209 5

    PATEL SUSHIL - Officer CHIEF STRATEGY OFFICER

    		2023-04-04 20:01:02 -0400 2023-04-01 A 60,000 a 60,000 direct

    PATEL SUSHIL - Officer CHIEF STRATEGY OFFICER

    		2023-04-04 20:01:02 -0400 2023-04-01 A 40,000 a 170,146 direct 1.3931 -1.4537 18.9582 18.9582 31 -5.209 5

    LEWIS TANYA - Officer CHIEF DEV. OP. OFFICER

    		2023-04-04 20:01:20 -0400 2023-04-01 A 60,000 a 60,000 direct

    LEWIS TANYA - Officer CHIEF DEV. OP. OFFICER

    		2023-04-04 20:01:20 -0400 2023-04-01 A 40,000 a 160,360 direct 1.3931 -1.4537 18.9582 18.9582 31 -5.209 5

    LOVE COLIN - Officer CHIEF OPERATING OFFICER

    		2023-04-04 20:01:29 -0400 2023-04-01 A 60,000 a 60,000 direct

    LOVE COLIN - Officer CHIEF OPERATING OFFICER

    		2023-04-04 20:01:29 -0400 2023-04-01 A 40,000 a 805,735 direct 1.3931 -1.4537 18.9582 18.9582 31 -5.209 5

    FRANCHI JEAN M. - Officer CHIEF FINANCIAL OFFICER

    		2023-04-04 20:01:58 -0400 2023-04-01 A 67,500 a 67,500 direct

    FRANCHI JEAN M. - Officer CHIEF FINANCIAL OFFICER

    		2023-04-04 20:01:58 -0400 2023-04-01 A 45,000 a 140,099 direct 1.3931 -1.4537 18.9582 18.9582 31 -5.209 5

    XYNOS KONSTANTINOS - Officer CHIEF MEDICAL OFFICER

    		2023-04-04 20:02:11 -0400 2023-04-01 A 75,000 a 75,000 direct

    XYNOS KONSTANTINOS - Officer CHIEF MEDICAL OFFICER

    		2023-04-04 20:02:11 -0400 2023-04-01 A 50,000 a 120,798 direct 1.3931 -1.4537 18.9582 18.9582 31 -5.209 5

    ESPOSITO PAMELA - Officer CHIEF BUSINESS OFFICER

    		2023-04-04 20:02:29 -0400 2023-04-01 A 60,000 a 60,000 direct

    ESPOSITO PAMELA - Officer CHIEF BUSINESS OFFICER

    		2023-04-04 20:02:29 -0400 2023-04-01 A 40,000 a 269,402 direct 1.3931 -1.4537 18.9582 18.9582 31 -5.209 5

    ASTLEY-SPARKE PHILIP - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-04-04 20:00:30 -0400 2023-04-01 A 213,150 a 213,150 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    REPLIMUNE GROUP INC REPL 2023-05-31 22:15:04 UTC 4.8051 0.2549 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 21:45:04 UTC 4.8051 0.2549 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 21:15:03 UTC 4.8051 0.2549 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 20:45:04 UTC 4.8051 0.2549 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 20:15:06 UTC 4.8051 0.2549 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 19:45:04 UTC 4.8051 0.2549 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 19:15:21 UTC 4.8051 0.2549 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 18:45:03 UTC 4.8051 0.2549 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 18:15:04 UTC 4.8051 0.2549 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 17:45:03 UTC 4.8051 0.2549 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 17:15:05 UTC 4.8051 0.2549 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 16:45:04 UTC 4.817 0.253 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 16:15:04 UTC 4.817 0.253 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 15:45:03 UTC 4.817 0.253 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 15:15:04 UTC 4.817 0.253 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 14:45:04 UTC 4.817 0.253 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 14:15:03 UTC 4.817 0.253 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 13:45:04 UTC 4.7999 0.2701 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 13:15:04 UTC 4.7999 0.2701 1600000
    REPLIMUNE GROUP INC REPL 2023-05-31 12:45:04 UTC 4.7999 0.2701 1600000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Enhanced Index Plus Fund REPL -70.0 shares, $-697.9 2020-03-31 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund REPL -46.0 shares, $-458.62 2020-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments